These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1293724)

  • 1. An in vitro bioassay for quantification of melarsoprol in serum and cerebrospinal fluid.
    Burri C; Brun R
    Trop Med Parasitol; 1992 Dec; 43(4):223-5. PubMed ID: 1293724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic properties of the trypanocidal drug melarsoprol.
    Burri C; Baltz T; Giroud C; Doua F; Welker HA; Brun R
    Chemotherapy; 1993; 39(4):225-34. PubMed ID: 8391966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phenomenon of treatment failures in Human African Trypanosomiasis.
    Brun R; Schumacher R; Schmid C; Kunz C; Burri C
    Trop Med Int Health; 2001 Nov; 6(11):906-14. PubMed ID: 11703845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An automated biological assay to determine levels of the trypanocidal drug melarsoprol in biological fluids.
    Onyango JD; Burri C; Brun R
    Acta Trop; 2000 Jan; 74(1):95-100. PubMed ID: 10643913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of trypanocidal therapy on the haematology of vervet monkeys experimentally infected with Trypanosoma brucei rhodesiense.
    Ngotho M; Kagira JM; Kariuki C; Maina N; Thuita JK; Mwangangi DM; Farah IO; Hau J
    Acta Trop; 2011 Jul; 119(1):14-8. PubMed ID: 21420376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma brucei rhodesiense: use of an antigen detection enzyme immunoassay for evaluation of response to chemotherapy in infected vervet monkeys (Cercopithecus aethiops).
    Gichuki CW; Nantulya VM; Sayer PD
    Trop Med Parasitol; 1994 Sep; 45(3):237-42. PubMed ID: 7899795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vivo resistance to strains of Trypanosoma rhodesiense, Mozambique, 1985].
    Pérez Martín O; Lastre González M; Urban M; Shwalbach J
    Rev Cubana Med Trop; 1991; 43(3):189-93. PubMed ID: 9768188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The monitoring of trypanocidal treatment with a sensitive ELISA method for measuring melarsoprol levels in serum and in cerebrospinal fluids.
    Maes L; Vanderveken M; Hamers R; Doua F; Cattand P
    Ann Soc Belg Med Trop; 1988 Sep; 68(3):219-31. PubMed ID: 3223784
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of melarsoprol in biological fluids by high-performance liquid chromatography and characterisation of two stereoisomers by nuclear magnetic resonance spectroscopy.
    Ericsson O; Schweda EK; Bronner U; Rombo L; Fridén M; Gustafsson LL
    J Chromatogr B Biomed Sci Appl; 1997 Mar; 690(1-2):243-51. PubMed ID: 9106049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-resistance of Trypanosoma b. rhodesiense isolates from Tanzania.
    Kibona SN; Matemba L; Kaboya JS; Lubega GW
    Trop Med Int Health; 2006 Feb; 11(2):144-55. PubMed ID: 16451338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-alpha-difluoromethylornithine (DFMO).
    Iten M; Matovu E; Brun R; Kaminsky R
    Trop Med Parasitol; 1995 Sep; 46(3):190-4. PubMed ID: 8533023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Melarsoprol].
    Simon F
    Med Trop (Mars); 1999; 59(4):331-2. PubMed ID: 10816741
    [No Abstract]   [Full Text] [Related]  

  • 13. Melarsoprol- and pentamidine-resistant Trypanosoma brucei rhodesiense populations and their cross-resistance.
    Bernhard SC; Nerima B; Mäser P; Brun R
    Int J Parasitol; 2007 Nov; 37(13):1443-8. PubMed ID: 17602691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancy in plasma melarsoprol concentrations between HPLC and bioassay methods in patients with T. gambiense sleeping sickness indicates that melarsoprol is metabolized.
    Bronner U; Brun R; Doua F; Ericsson O; Burri C; Keiser J; Miézan TW; Boa YF; Rombo L; Gustafsson LL
    Trop Med Int Health; 1998 Nov; 3(11):913-7. PubMed ID: 9855405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda.
    Matovu E; Enyaru JC; Legros D; Schmid C; Seebeck T; Kaminsky R
    Trop Med Int Health; 2001 May; 6(5):407-11. PubMed ID: 11348535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations of the metabolites of the trypanocidal drug melarsoprol.
    Keiser J; Ericsson O; Burri C
    Clin Pharmacol Ther; 2000 May; 67(5):478-88. PubMed ID: 10824626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The sleep-wake cycle during Trypanosoma brucei rhodesiense human African trypanosomiasis in 2 French parachutists].
    Montmayeur A; Brosset C; Imbert P; Buguet A
    Bull Soc Pathol Exot; 1994; 87(5):368-71. PubMed ID: 7496202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of multiple drug resistance in Trypanosoma brucei rhodesiense isolated from sleeping sickness patients.
    Kagira JM; Maina N
    Onderstepoort J Vet Res; 2007 Mar; 74(1):17-22. PubMed ID: 17708149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Veterinary link to drug resistance in human African trypanosomiasis?
    Barrett MP
    Lancet; 2001 Aug; 358(9282):603-4. PubMed ID: 11530144
    [No Abstract]   [Full Text] [Related]  

  • 20. [A trial treatment with eflornithine of trypanosomiasis caused by Trypanosoma brucei gambiense in the Peoples Republic of the Congo].
    Eozenou P; Jannin J; Ngampo S; Carme B; Tell GP; Schechter PJ
    Med Trop (Mars); 1989; 49(2):149-54. PubMed ID: 2507863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.